About BCF Life Sciences
BCF Life Sciences is a company based in Pleucadeuc (France) founded in 1986 was acquired by MBO & Co in June 2018.. BCF Life Sciences offers products and services including Kera-Diet®, Free Amino Acids, and Plant Biostimulant Solutions. BCF Life Sciences operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Pleucadeuc, France
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$170.15 K (USD), Grant
Nov 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
-
Acquired by
MBO & Co
(Jun 21, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BCF Life Sciences
BCF Life Sciences offers a comprehensive portfolio of products and services, including Kera-Diet®, Free Amino Acids, and Plant Biostimulant Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Supplement supporting hair and nail growth through amino acids.
Essential building blocks for proteins in health applications.
Natural amino acids enhancing plant growth and sustainability.
Unlock access to complete
Funding Insights of BCF Life Sciences
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $170,150
-
First Round
First Round
(01 Nov 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Grant - BCF Life Sciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BCF Life Sciences
BCF Life Sciences has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and MBO+. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment support is provided to managers and entrepreneurs by MBO+.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BCF Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BCF Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bcf Life Sciences Comparisons
Competitors of BCF Life Sciences
BCF Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bcf Life Sciences
Frequently Asked Questions about BCF Life Sciences
When was BCF Life Sciences founded?
BCF Life Sciences was founded in 1986 and raised its 1st funding round 37 years after it was founded.
Where is BCF Life Sciences located?
BCF Life Sciences is headquartered in Pleucadeuc, France. It is registered at Pleucadeuc, Morbihan, France.
What does BCF Life Sciences do?
BCF Life Sciences was established in 1986 in Pleucadeuc, France, within the life sciences sector. Operations center on the production of natural amino acids such as L-Cystine and L-Tyrosine, along with derivatives including Carbocisteine. Non-allogenic proteins are supplied to pharmaceutical and healthcare industries, while highly digestible proteins support human, animal, and plant nutrition. A dedicated RD team of six engineers conducts nearly 4000 analyses monthly using 80 physicochemical methods.
Who are the top competitors of BCF Life Sciences?
BCF Life Sciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does BCF Life Sciences offer?
BCF Life Sciences offers Kera-Diet®, Free Amino Acids, and Plant Biostimulant Solutions.
Who are BCF Life Sciences's investors?
BCF Life Sciences has 2 investors. Key investors include European Union, and MBO+.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.